{
  "id": 12278247,
  "title": "Japan's Shionogi to Buy U.S. Bioventure for 2 B. Dollars",
  "url": "https://urgent.news/2026/10/06/japans-shionogi-to-buy-u-s-bioventure-for-2-b-dollars",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-06T01:31:40.000Z",
  "source": {
    "name": "Nippon.com News",
    "slug": "nippon-com-news",
    "url": "https://www.nippon.com/en/news/yjj2026100500922/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Osaka, Oct. 6 (Jiji Press)--Major Japanese drugmaker Shionogi & Co. has said that it will acquire U.S. biopharmaceutical company IntraBio Inc. for 2 billion dollars as part of efforts to strengthen its rare disease drug business. Shionogi will buy all outstanding shares in the Austin, Texas-based company, according to an announcement Monday. Founded in 2015, IntraBio develops and commerci...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}